Pathology

Dr. Öğr. Üyesi Tuçe Söylemez Akkurt

Doctor and researcher Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi İstanbul
Brain NeoplasmsBreast NeoplasmsEndometrial NeoplasmsGliomaOligodendrogliomaKidney Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Brain Neoplasms 5 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Breast Neoplasms 4 publications
  • Endometrial Neoplasms 3 publications
  • Glioma 2 publications
  • Oligodendroglioma 2 publications
  • Kidney Neoplasms 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPathologysaglik.gov.trFrom source
  • InstitutionGöztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesisaglik.gov.trFrom source
  • Area of workBrain NeoplasmsExtracted from 5 publications · Model version —From source
  • Publications61 publicationsOpenAlex, Europe PMC, ORCIDFrom source
  • ORCID0000-0003-3030-7030ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://suleymanyalcinsh.saglik.gov.tr/TR-1493897/doktorlarimiz.html#tuce-soylemez-akkurtsaglik.gov.tr

Scientific work

Publications on Brain Neoplasms

61 publications

  1. Baseline [¹⁸F]FDG PET/CT metrics and systemic inflammatory indices in relation to overall survival in a real-world breast cancer cohort

    Clinical and Translational Imaging, 2026

    DOI 10.1007/s40336-026-00767-7 Source: OpenAlex

  2. Integrating PET/CT-derived heterogeneity indices and composite risk scores improves prognostic stratification in breast cancer

    European journal of nuclear medicine and molecular imaging, 2026

    DOI 10.1007/s00259-025-07622-3 PMID 41191096 2 citations (Europe PMC) Source: Europe PMC

  3. Baseline FDG PET/CT–Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer

    Nuklearmedizin - NuclearMedicine, 2026

    DOI 10.1055/a-2825-4883 PMID 42167287 Source: OpenAlex

  4. Clinicopathologic and prognostic significance of FOLR1 expression in gastric adenocarcinoma and its association with PD-L1, HER2, MMR, and p53 status

    Virchows Archiv : an international journal of pathology, 2026

    DOI 10.1007/s00428-026-04455-9 PMID 41758267 Open-access full textSource: Europe PMC

  5. NF1-ASSOCIATED MIDLINE HIGH-GRADE ASTROCYTOMA WITH PILOID FEATURES ARISING IN THE DORSAL THALAMUS: A DIAGNOSTIC CONSIDERATION

    Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2026

    DOI 10.26650/iuitfd.1913731 Open-access full textSource: ORCID

  6. RB1 Loss as a Diagnostic Clue in a High‐Grade Glioma With Pleomorphic and Pseudopapillary Features (HPAP): The First Reported Case With Spinal Metastasis and a Review of the Literature

    Pathology International, 2026

    DOI 10.1111/pin.70150 PMID 42482402 Open-access full textSource: ORCID

  7. A PMS2-deficient pediatric high-grade glioma with PI3K-pathway mutations and adjacent developmental venous anomaly suggestive of CMMRD

    Child's Nervous System, 2026

    DOI 10.1007/s00381-026-07230-y PMID 41886087 Open-access full textSource: ORCID

  8. Radiomic signatures derived from baseline 18F FDG PET/CT imaging can predict tumor-infiltrating lymphocyte values in patients with primary breast cancer

    Nuklearmedizin - NuclearMedicine, 2025

    DOI 10.1055/a-2512-8212 PMID 39875129 2 citations (Europe PMC) Source: OpenAlex

  9. Colorectal carcinoma with sarcomatoid component: isolated SMARCA2 loss and high PD ‐ L1 expression as a potential therapeutic target

    Histopathology, 2025

    DOI 10.1111/his.70012 PMID 40981612 Source: ORCID

  10. Clinicopathological features of Russell Body-associated gastrointestinal lesions

    VIRCHOWS ARCHIV, 2025

    Source: ORCID

View all 61 publications